ES2170874T3 - Procedimiento para preparar farmacos anti-malaria. - Google Patents

Procedimiento para preparar farmacos anti-malaria.

Info

Publication number
ES2170874T3
ES2170874T3 ES96934646T ES96934646T ES2170874T3 ES 2170874 T3 ES2170874 T3 ES 2170874T3 ES 96934646 T ES96934646 T ES 96934646T ES 96934646 T ES96934646 T ES 96934646T ES 2170874 T3 ES2170874 T3 ES 2170874T3
Authority
ES
Spain
Prior art keywords
malaria
rent
pharmacos
procedure
prepare anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934646T
Other languages
English (en)
Inventor
Cletus Onwuzurike Ugwuegbulam
James Edward Foy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2170874T3 publication Critical patent/ES2170874T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

LA INVENCION SE REFIERE A NUEVOS INTERMEDIOS Y PROCESOS PARA LA PREPARACION DE COMPUESTOS DE QUINOLINA UTILES COMO DROGAS CONTRA LA MALARIA Y NUEVOS INTERMEDIOS UTILES EN EL PROCESO. UN PROCESO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA (I) EN DONDE R 1 ES ALQUILO C 1-6 ; R 2 Y R 3 SON INDEPENDIENTEMENTE HIDROGENO, HALOGENO, TIFLUOROMETILO O ALCOXI C 1-6 ; R 4 ES ALQUILO C 1-6 ; R 5 ES H IDROGENO O ALQUILO C 1-6 ; Y R 6 ES NITRO O AMINO, QUE INCLUYE LA REACCION DE UN COMPUESTO DE FORMULA (II) EN DONDE R 1 , R 4 Y R 5 SON COMO SE DEFINE EN LA FORMULA (I) Y X ES UN GRUPO DIRECTRIZ CON UN COMPUESTO DE FORMULA (III).
ES96934646T 1995-10-13 1996-10-11 Procedimiento para preparar farmacos anti-malaria. Expired - Lifetime ES2170874T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521004.3A GB9521004D0 (en) 1995-10-13 1995-10-13 Process

Publications (1)

Publication Number Publication Date
ES2170874T3 true ES2170874T3 (es) 2002-08-16

Family

ID=10782264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934646T Expired - Lifetime ES2170874T3 (es) 1995-10-13 1996-10-11 Procedimiento para preparar farmacos anti-malaria.

Country Status (28)

Country Link
US (1) US6479660B1 (es)
EP (1) EP0871616B1 (es)
JP (1) JP4083803B2 (es)
KR (1) KR100453256B1 (es)
CN (1) CN1147475C (es)
AR (1) AR004015A1 (es)
AT (1) ATE214372T1 (es)
AU (1) AU709333B2 (es)
BR (1) BR9611010A (es)
CA (1) CA2231633C (es)
CZ (1) CZ290380B6 (es)
DE (1) DE69619863T2 (es)
DK (1) DK0871616T3 (es)
ES (1) ES2170874T3 (es)
GB (1) GB9521004D0 (es)
HK (1) HK1016180A1 (es)
HU (1) HUP9900739A3 (es)
IL (1) IL124060A (es)
NO (1) NO313285B1 (es)
NZ (1) NZ320209A (es)
PL (1) PL186055B1 (es)
PT (1) PT871616E (es)
SA (1) SA97170574B1 (es)
SI (1) SI0871616T1 (es)
TR (1) TR199800637T2 (es)
TW (1) TW450950B (es)
WO (1) WO1997013753A1 (es)
ZA (1) ZA968550B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08276712A (ja) * 1995-04-05 1996-10-22 Masao Tsuji チュ−ブレススパイクタイヤ
GB0210150D0 (en) * 2002-05-03 2002-06-12 Smithkline Beecham Plc Process
WO2007032016A1 (en) * 2005-09-12 2007-03-22 Council Of Scientific And Industrial Research An antimalarial baylis-hillman adducts and a process for the preparation thereof
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
GB0620005D0 (en) 2006-10-10 2006-11-22 Glaxo Group Ltd Compounds
US20090076072A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched tafenoquine
ES2453206B1 (es) 2013-09-25 2015-01-12 Thyssenkrupp Elevator Innovation Center, S.A. Sistema de tracción para un sistema de transporte
CN113248431A (zh) * 2021-05-21 2021-08-13 重庆医药高等专科学校 一种磷酸伯氨喹的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US4617394A (en) 1985-10-15 1986-10-14 The United States Of America As Represented By The Secretary Of The Army 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines

Also Published As

Publication number Publication date
NZ320209A (en) 1999-08-30
KR100453256B1 (ko) 2004-12-17
NO313285B1 (no) 2002-09-09
HUP9900739A2 (hu) 1999-09-28
AU709333B2 (en) 1999-08-26
SA97170574B1 (ar) 2006-09-25
ATE214372T1 (de) 2002-03-15
US6479660B1 (en) 2002-11-12
DE69619863T2 (de) 2002-11-21
EP0871616A1 (en) 1998-10-21
BR9611010A (pt) 1999-07-13
IL124060A (en) 2003-07-31
AR004015A1 (es) 1998-09-30
JPH11513399A (ja) 1999-11-16
PL186055B1 (pl) 2003-09-30
PT871616E (pt) 2002-07-31
TW450950B (en) 2001-08-21
NO981537L (no) 1998-04-03
JP4083803B2 (ja) 2008-04-30
AU7291096A (en) 1997-04-30
HK1016180A1 (en) 1999-10-29
CZ110398A3 (cs) 1998-09-16
CN1199395A (zh) 1998-11-18
ZA968550B (en) 1998-04-14
CZ290380B6 (cs) 2002-07-17
WO1997013753A1 (en) 1997-04-17
EP0871616B1 (en) 2002-03-13
PL326194A1 (en) 1998-08-31
CA2231633A1 (en) 1997-04-17
DK0871616T3 (da) 2002-07-01
TR199800637T2 (xx) 1998-07-21
GB9521004D0 (en) 1995-12-13
HUP9900739A3 (en) 1999-11-29
SI0871616T1 (en) 2002-12-31
KR19990064210A (ko) 1999-07-26
DE69619863D1 (de) 2002-04-18
CA2231633C (en) 2006-10-03
CN1147475C (zh) 2004-04-28
NO981537D0 (no) 1998-04-03

Similar Documents

Publication Publication Date Title
MX9704433A (es) Procedimiento para la preparacion de sildenafil.
ATE143941T1 (de) Salpetersäureester von 2-(2,6- dihalophenylamino)phenylessigsäurederivaten und verfahren zu ihrer herstellung
ES2170874T3 (es) Procedimiento para preparar farmacos anti-malaria.
MX9305364A (es) Compuestos inhibidores de proteasa retroviral, metodo para su produccion y composicion farmaceutica que los comprende.
PT934261E (pt) Processo para a producao de ditiobis-alcanossulfonatos e fosfonatos
BR9509373A (pt) Processo para a preparação de 3- aminobenzonitrilas substituídas
ES2076196T3 (es) Procedimiento para la produccion de derivados de acido 3,5,6-trihidroxihexanoico.
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
ES2139189T3 (es) Procedimiento para la preparacion de derivados de acido cinamico.
NO308658B1 (no) Sammenføyde isoquinoliner som dopamin-reseptor-ligander
DE69807073T2 (de) Herstellung von tri-iodo-benzol-verbindungen
ES2174345T3 (es) Procedimiento para la preparacion de esteres del acido 2,6 piridindicarboxilicos.
ES2193568T3 (es) Procedimiento de preparacion de lactamas n-derivadas enriquecidas enantiomericamente.
GB1460409A (en) Process for the manufacture 'f di- and triamino naphthalenes
BR9908511A (pt) Processo para a preparação de um composto, e, composto
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
PT1001929E (pt) Processo para o fabrico de acidos 3-ciano-2,4-di-halogeno-5-fluorobenzoicos
BR9902525A (pt) Processo para compostos de ácido pirrolidinil-hidroxâmico
SE9802939D0 (sv) New process
ES2145905T3 (es) Procedimiento de produccion de acido 3-isoxazolcarboxilico.
ES2042409B1 (es) Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos.
ATE34169T1 (de) Verfahren zur herstellung von methyl-nmethylanthranilat.
DE69821763D1 (de) Verfahren zur herstellung von 2-alkylthio-substituierten benzoesäurederivaten
AR012147A1 (es) UN PROCESO PARA PREPARAR UN COMPUESTO TRICíCLICO ,UN PROCESO PARA LA PREPARACIoN DE UN COMPUESTO INTERMEDIARIO IODOSUSTITUIDO , Y COMPUESTO INTERMEDIARIO

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 871616

Country of ref document: ES